Kvietys P R, Granger D N
Am J Physiol. 1982 Jul;243(1):G1-9. doi: 10.1152/ajpgi.1982.243.1.G1.
Many vasoactive agents are known to alter oxygen uptake by splanchnic organs. Data from the literature indicate that, in general, vasodilators increase, whereas vasoconstrictors decrease oxygen uptake. We compare and contrast the effects of vasoactive agents on oxygen uptake observed in vivo, under constant-flow and free-flow conditions, to those observed in vitro. The discrepancies between the in vivo and in vitro data are discussed relative to the effects of vasoactive agents on blood flow, intraorgan blood flow distribution, the countercurrent exchange of oxygen, capillary exchange capacity, and oxidative metabolism. Changes in blood flow, oxidative metabolism, and capillary density appear to be the major mechanisms by which vasoactive agents alter splanchnic oxygen uptake in vivo. Experimental designs are proposed that may help minimize inconsistencies in the data in future studies.
已知许多血管活性药物会改变内脏器官的氧摄取。文献数据表明,一般来说,血管扩张剂会增加氧摄取,而血管收缩剂会减少氧摄取。我们比较并对比了在恒定流量和自由流动条件下,血管活性药物在体内和体外观察到的对氧摄取的影响。相对于血管活性药物对血流、器官内血流分布、氧的逆流交换、毛细血管交换能力和氧化代谢的影响,讨论了体内和体外数据之间的差异。血流、氧化代谢和毛细血管密度的变化似乎是血管活性药物在体内改变内脏氧摄取的主要机制。本文提出了一些实验设计,可能有助于在未来的研究中尽量减少数据的不一致性。